ATE60903T1 - Stabile, waessrige vincristinsulfatloesung. - Google Patents
Stabile, waessrige vincristinsulfatloesung.Info
- Publication number
- ATE60903T1 ATE60903T1 AT87400960T AT87400960T ATE60903T1 AT E60903 T1 ATE60903 T1 AT E60903T1 AT 87400960 T AT87400960 T AT 87400960T AT 87400960 T AT87400960 T AT 87400960T AT E60903 T1 ATE60903 T1 AT E60903T1
- Authority
- AT
- Austria
- Prior art keywords
- vincristine sulfate
- stable
- aqueous solution
- sulfate aqueous
- solution
- Prior art date
Links
- AQTQHPDCURKLKT-JKDPCDLQSA-N vincristine sulfate Chemical compound OS(O)(=O)=O.C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C=O)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 AQTQHPDCURKLKT-JKDPCDLQSA-N 0.000 title abstract 2
- 229960002110 vincristine sulfate Drugs 0.000 title abstract 2
- 239000007864 aqueous solution Substances 0.000 title 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 abstract 2
- 239000000243 solution Substances 0.000 abstract 2
- 239000004471 Glycine Substances 0.000 abstract 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 abstract 1
- 235000019796 monopotassium phosphate Nutrition 0.000 abstract 1
- 239000008363 phosphate buffer Substances 0.000 abstract 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 abstract 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 230000002335 preservative effect Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 239000008215 water for injection Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8606030A FR2597750B1 (fr) | 1986-04-25 | 1986-04-25 | Solution aqueuse stable de sulfate de vincristine |
| EP87400960A EP0243278B1 (de) | 1986-04-25 | 1987-04-24 | Stabile, wässrige Vincristinsulfatlösung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE60903T1 true ATE60903T1 (de) | 1991-03-15 |
Family
ID=9334638
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT87400960T ATE60903T1 (de) | 1986-04-25 | 1987-04-24 | Stabile, waessrige vincristinsulfatloesung. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4966903A (de) |
| EP (1) | EP0243278B1 (de) |
| JP (1) | JPS62273918A (de) |
| AT (1) | ATE60903T1 (de) |
| CA (1) | CA1303510C (de) |
| DE (1) | DE3768043D1 (de) |
| ES (1) | ES2020671B3 (de) |
| FR (1) | FR2597750B1 (de) |
| GR (1) | GR3001767T3 (de) |
| ZA (1) | ZA872877B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2623089B1 (fr) * | 1987-11-13 | 1990-04-27 | Pf Medicament | Composition pharmaceutique pour l'administration parenterale de navelbine |
| HU204995B (en) * | 1989-11-07 | 1992-03-30 | Richter Gedeon Vegyeszet | Process for producing pharmaceutical composition comprising alkaloid with bis-indole skeleton, with antitumour activity and suitable fr parenteral purposes |
| US20110015221A1 (en) * | 2003-12-23 | 2011-01-20 | Pierre Fabre Medicament | Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same |
| FR2863891B1 (fr) * | 2003-12-23 | 2006-03-24 | Pf Medicament | Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation |
| CA2920584A1 (en) * | 2013-08-07 | 2015-02-12 | Xagenic Inc. | Microchip structure and treatments for electrochemical detection |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1254057A (en) * | 1969-04-24 | 1971-11-17 | Louisette Olivier | Improvements in or relating to therapeutical composition containing vincamine |
| US3749784A (en) * | 1972-05-03 | 1973-07-31 | Lilly Co Eli | Psoriasis treatment |
| JPS58208222A (ja) * | 1982-05-28 | 1983-12-03 | Japan Found Cancer | 抗腫瘍剤効果増強剤 |
| IT1170152B (it) * | 1982-07-19 | 1987-06-03 | Lilly Co Eli | Miglioramenti a o riguardanti formulazioni di vinca-alcaloidi |
| US4619935A (en) * | 1983-03-17 | 1986-10-28 | Eli Lilly And Company | Stable oncolytic formulations |
-
1986
- 1986-04-25 FR FR8606030A patent/FR2597750B1/fr not_active Expired
-
1987
- 1987-04-23 ZA ZA872877A patent/ZA872877B/xx unknown
- 1987-04-24 DE DE8787400960T patent/DE3768043D1/de not_active Expired - Lifetime
- 1987-04-24 ES ES87400960T patent/ES2020671B3/es not_active Expired - Lifetime
- 1987-04-24 CA CA000535495A patent/CA1303510C/fr not_active Expired - Lifetime
- 1987-04-24 EP EP87400960A patent/EP0243278B1/de not_active Expired - Lifetime
- 1987-04-24 AT AT87400960T patent/ATE60903T1/de not_active IP Right Cessation
- 1987-04-24 JP JP62100242A patent/JPS62273918A/ja active Pending
-
1988
- 1988-10-13 US US07/257,148 patent/US4966903A/en not_active Expired - Lifetime
-
1991
- 1991-04-11 GR GR91400479T patent/GR3001767T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2020671B3 (es) | 1991-09-01 |
| EP0243278B1 (de) | 1991-02-20 |
| FR2597750B1 (fr) | 1989-06-02 |
| CA1303510C (fr) | 1992-06-16 |
| JPS62273918A (ja) | 1987-11-28 |
| ZA872877B (en) | 1987-10-12 |
| FR2597750A1 (fr) | 1987-10-30 |
| GR3001767T3 (en) | 1992-11-23 |
| DE3768043D1 (de) | 1991-03-28 |
| US4966903A (en) | 1990-10-30 |
| EP0243278A1 (de) | 1987-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8603271A1 (es) | Un metodo de producir una composicion de interleuquina-2 | |
| MX162265A (es) | Procedimiento mejorado para la preparacion de acido 4-dimetilamino-1-hidro-xibutano-1,1-difosfonico | |
| ES2113652T3 (es) | Pamoato de risperidona. | |
| DK235584D0 (da) | Fremgangsmaade til fremstilling af et valleprodukt | |
| NO930294L (no) | Stabil fibrinogenopploesning | |
| DE68910377D1 (de) | Kosmetisches Präparat. | |
| FI845004L (fi) | Munskoeljningsloesning. | |
| FI873672A0 (fi) | Kompositioner innehaollande l-3,4-dihydroxifenylalanin. | |
| EP0156924A4 (de) | Chemisch aktive zusammensetzung ferro-ionen enthaltend. | |
| BG46451A3 (en) | Herbicide means | |
| NO902488L (no) | Karboplatinapreparat. | |
| DE3768043D1 (de) | Stabile, waessrige vincristinsulfatloesung. | |
| DE3863859D1 (de) | Stabile, injizierbare loesungen von salzen von vincristin. | |
| ES8708220A1 (es) | Procedimiento para la obtencion de halogeno-hidroxi-flavonas | |
| AU564269B2 (en) | Compositions containing s-adenosyl-l methionine | |
| ATE63810T1 (de) | Nicardipin-hydrochlorid-injektionsloesungen sowie deren herstellung. | |
| DK0523406T3 (da) | Anvendelse af tri-(n-butyl)-phosphat ved lavt pH i opløsninger af biologisk aktive proteiner til forøget virucid virkning | |
| NO883520D0 (no) | Fremgangsmaate for fremstilling av et injeksjonspreparat. | |
| FR2558481B1 (fr) | Procede de preparation de l'acide 4-amino-3-hydroxybutyrique optiquement actif | |
| DK0686694T3 (da) | Anvendelse af azoler som virucide midler i opløsninger af biologisk aktive proteiner | |
| EP0142597A3 (en) | Curative composition for buerger's disease | |
| FR2543143B1 (fr) | Esters dioxolenylmethyliques de l'acide phosphinique, a action antihypertensive | |
| ATE42460T1 (de) | Konzentrierte waessrige tensidloesung. | |
| SE9202434D0 (sv) | Skatolinaktiverande komposition | |
| ES2067140T3 (es) | Compuestos fenilester de acido benzoico y composiciones inhibidoras de la elastasa que contienen los mismos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EELA | Cancelled due to lapse of time |